Advertising Botox and Fillers in Singapore: HSA Rules for Clinics
Summary: In Singapore, botulinum toxin is a prescription-only medicine and hyaluronic acid dermal fillers are professional-use-only medical devices, and HSA does not allow either to be advertised to the public. Aesthetic clinics can talk about conditions, consultations and treatments in generic terms, but not brand names, product images, brand comparisons or offers to pre-select a product. These Health Products Act rules apply on top of the HCSA advertising regulations and SMC's aesthetic guidelines.
Key takeaways
- Botulinum toxin is classified by HSA as a prescription-only medicine, and hyaluronic acid dermal fillers as professional-use-only medical devices. Neither may be advertised to the public.
- HSA treats brand names, nicknames, deliberate misspellings and product photos as advertising, so 'Botox', 'B0tox' and a photo of the vial are all out of public-facing content.
- Generic terms such as 'botulinum toxin' and 'dermal fillers' are allowed in balanced, educational content about a condition and its treatment options.
- Calls to action that let patients pre-select a product before a consultation, such as 'Book your Botox' or a quiz that ends in a product, count as an offer of sale.
- HCSA rules still apply on top: no before/after images, testimonials, endorsements, superlatives or promotional offers.
In this guide
Most aesthetic clinics I speak to know the HCSA advertising rules by now. No before/after photos, no testimonials, no "best clinic in Orchard". What fewer of them realise is that injectables bring in a second regulator. The moment an ad mentions a specific toxin or filler, it is also advertising a health product, and that falls under the Health Sciences Authority (HSA).
That second set of rules is where we see the most problems in aesthetic marketing. "Botox from $X" on a banner, a vial in a reel, a creator tagging a filler brand. All very common, and all a problem under the Health Products Act.
From this guide, you will learn:
- how HSA classifies botulinum toxin and dermal fillers, and why that matters for advertising
- what you can't name or show in ads, posts and landing pages, including the workarounds HSA has already ruled out
- what you can still say about injectable treatments
- how HSA's rules stack with the HCSA advertising regulations and the SMC aesthetic guidelines
- how to handle KOL and influencer posts, with before-and-after rewrites and a checklist
A caution before we start. I run a marketing agency; I'm not a lawyer. This is how my team reads and applies the rules day to day. Check the current texts yourself, and speak to HSA or a lawyer about anything borderline. HSA says plainly in its guidance that it does not vet individual ads.
Two regulators, two sets of rules
An aesthetic clinic's ads answer to two separate regimes at once:
- The service. Advertising a licensable healthcare service, such as your clinic's aesthetic consultations, is governed by the Healthcare Services Act 2020 and the Healthcare Services (Advertisement) Regulations 2021, administered by MOH. I cover these in detail in our HCSA advertising guide.
- The product. Advertising a health product is governed by the Health Products Act and its subsidiary legislation, administered by HSA. For medicines, the key instrument is the Health Products (Advertisement of Specified Health Products) Regulations 2016. For devices, it is the Health Products (Medical Devices) Regulations.
The Health Products Act defines an advertisement broadly: any information published to promote, directly or indirectly, the sale or use of a health product. HSA's guidance for HCSA licensees (November 2024) lists websites, social media such as Facebook, Instagram and TikTok, brochures and email mailers as examples. So your clinic website, your Instagram grid and your Google Ads are all in scope.
You may see older articles mention the Medicines Act. For botulinum toxin and other western medicines, HSA's current guidance to clinics points to the Health Products Act and the regulations above, so that is where I'd focus.
How HSA classifies botulinum toxin and fillers
Everything depends on how the product is classified. HSA's guidance for licensees sets this out in its appendix:
- Botulinum toxin is a prescription-only medicine (POM). HSA lists "aesthetic medicines (e.g. botulinum toxin, deoxycholic acid)" among its examples of POMs, alongside medicines for chronic diseases and cancer drugs.
- Hyaluronic acid dermal fillers are professional-use-only medical devices (PUO MDs). These are devices that should only be used by, or under the supervision of, a registered doctor or dentist. HSA gives hyaluronic acid dermal fillers as an example.
The rule that follows is short. HSA's guidance states that POMs, PUO medical devices and cell, tissue or gene therapy products are not allowed to be advertised to the public, because the decision to use them depends on a doctor's clinical judgement and an informed discussion with the patient. In the regulations themselves, regulation 7 says no advertisement by a non-public sector person may relate to a prescription-only medicine. HSA's medical device advertising page says the same for PUO devices, unless the ad goes only to qualified practitioners.
For any other product you use, such as a skin booster, a thread or a topical, check its classification on HSA's Infosearch before you mention it anywhere public. HSA's FAQs point licensees to this tool.
What you can't name or show
HSA published FAQs for HCSA licensees alongside its guidance, and they are unusually specific. These are the areas that catch aesthetic clinics.
Brand names
The FAQs say that when you give the public information on treatment options, references to brand names are not allowed, and they name Botox and Profhilo as examples. That covers ad headlines, page titles, captions, hashtags, video voiceovers and on-screen text. HSA's guidance also says it looks at content in totality, including hashtags of product names.
Nicknames, misspellings and masked visuals
Clinics often try "B*tox", "Btx", "baby B" or an emoji. HSA has already ruled this out. Its FAQs say acronyms, deliberate misspellings, creative names and images with masked identifiers that refer to a POM or PUO device are still advertisements of that product.
Product photos and packaging
A photo of a branded vial, syringe box or injection pen is a reference to that product, even with no caption. HSA's FAQs list a visual of a product's packaging as an example of indirect advertising. Treatment-room shots are fine as long as no product is identifiable.
Pre-selecting a product before a consultation
This is the one that catches booking flows. HSA says patients should not be prompted to pre-select a POM or PUO device before a medical consultation. Its FAQs give examples of what isn't allowed: "Buy Now", "Add to Cart", "Check eligibility", "Start consultation", an online quiz or survey, or any visual tied to selecting the product before a consultation. You can invite people to a consultation about a condition. You can't invite them to book a product.
Brand comparisons
Comparison tables of different toxin or filler brands, or claims that one "lasts longer", "works faster" or is "preferred by our doctors", are specifically called out in HSA's FAQs as not allowed.
"HSA approved"
Claims that a product is approved or endorsed by HSA or any public authority are not allowed, according to both the guidance and the FAQs. "We only use HSA-approved fillers" is a very common line on aesthetic websites. Take it out.
Pricing tied to a product
HSA's FAQs say educational information on treatments should not include pricing, and that a product listing with a price and a call to action counts as an offer of sale. If you want to publish fees for injectable treatments, ask HSA's Medical Advertisements and Compliance Monitoring Unit (HSA_MA@hsa.gov.sg) or your lawyer first. The HCSA rules on pricing apply as well.
What you can still say
None of this means you have to stay silent about injectables. HSA's guidance is clear that factual, educational information about diseases and their management is not prohibited. The conditions are what make it work:
- Lead with the concern, not the product. HSA advises focusing on medical conditions and the healthcare services available. "Frown lines", "gummy smile", "volume loss in the mid-face" and "excessive sweating" are topics. Products are not.
- Use generic terms. Where a product type has to be mentioned, HSA allows therapeutic classes, active ingredients and generic technology terms. Its own examples include "botulinum toxins", "dermal fillers" and "PICO laser".
- Give the full picture. Educational content should be balanced: an overview of the condition, the range of treatment options, and their risks and benefits. A page that covers only one injectable for a concern reads as promotion.
- Talk about the consultation. What the doctor assesses, what questions to ask, typical recovery and side effects. This is useful to patients, and it is the content that tends to rank in search.
Doctor-led explainer videos work particularly well here. A doctor on camera explaining how muscle-relaxing injections work in general terms, who they're not suitable for and what to expect afterwards is compliant under both regimes and does well on Instagram, TikTok and Xiaohongshu.
How HSA rules stack with HCSA and SMC
Passing HSA's rules doesn't make an ad compliant. Each regime adds its own layer, and the strictest one wins on any given line.
HCSA advertising regulations
For the clinic service, the Healthcare Services (Advertisement) Regulations 2021 apply. The ones that matter most for aesthetic clinics:
- No before/after or after-only images of any treatment (regulation 5(1)(d)).
- No laudatory statements or superlatives (regulation 5(1)(e)), and nothing that creates an unjustified expectation (regulation 5(1)(c)).
- No reviews, testimonials or endorsements in your advertising, subject to the narrow exceptions in regulation 14. We treat them as off-limits.
- No promotional programmes that give patients a gift or benefit based on what they buy (regulation 15). Bundles such as "toxin plus a free skin booster" fail on both fronts, because HSA's guidance also says a therapeutic product can't be offered free or bundled with another health product.
Breaching section 31 of the Healthcare Services Act carries a fine of up to $20,000, imprisonment of up to 12 months, or both, on conviction (section 31(3)). On the HSA side, breaching the prescribed advertising requirements is an offence under section 21 of the Health Products Act, with the same maximum fine and term.
SMC Guidelines on Aesthetic Practices
The SMC Guidelines on Aesthetic Practices for Doctors (2016 edition) bind the individual doctor. Two points matter for marketing:
- The guidelines say doctors must ensure the content of any advertisements, especially images, and the way aesthetic procedures are described, are not misleading.
- Botulinum toxin injection and filler injection (face, neck and hands) appear in Table 1 as minimally invasive procedures. Doctors without the required track record need a Certificate of Competence before performing Table 1 procedures. So before a doctor's profile says they offer injectables, check they are allowed to. Our guide to doctor profile pages covers the rest.
KOL and influencer posts
Creator content is where aesthetic clinics take the most risk, because three rules hit at once:
- HCSA: content you pay for, arrange or exchange for a treatment is your advertising. A creator saying they love their results is a testimonial and an endorsement attached to your clinic.
- HSA: regulation 4 of the advertising regulations bans any endorsement or recommendation of a specified health product by a healthcare professional or by anyone whose celebrity, social or professional status is likely to encourage its use. That describes an influencer.
- HSA again: if the creator names the brand, tags the manufacturer or shows the packaging, it is also an advertisement of a POM or PUO device to the public.
HSA's guidance adds that materials jointly produced with the pharmaceutical industry are covered too, and both the provider and the company are responsible. So if a toxin or filler brand offers to co-fund a campaign with your clinic, the same rules apply to them and to you.
What we put in every aesthetic creator brief:
- no product brand names, nicknames, hashtags or tags, and no packaging in shot
- no results claims, no "before" footage, no "best" or "painless"
- no discount codes or "DM for promo"
- focus on the clinic, the consultation, and what the doctor explained
- clinic approves every caption and video before posting, and keeps the record
Honestly, for injectables I'd question whether paid creator content is worth it at all. Doctor-led content on your own channels carries less risk and builds more trust. Our social media marketing work for aesthetic clinics is built around that.
Rewriting typical aesthetic clinic ads
Here are ads in the style we see all the time, with how I would rewrite them. The areas are examples.
- Before: "Botox from $288! Smooth away frown lines this weekend." After: "Frown lines: what causes them and the treatment options available. Consultations with our doctors in Orchard."
- Before: "Juvederm vs Restylane: which lasts longer? Find out at our clinic." After: "Volume loss in the cheeks: how our doctors assess it, and the risks and benefits of each treatment option."
- Before: "We only use HSA-approved, authentic fillers. Book your filler slot now." After: "Book a consultation to discuss facial volume concerns with Dr [name]."
- Before: A quiz that ends in "You're a match for Profhilo! Book now." After: A page explaining skin quality concerns, the full range of options in generic terms, and a button to book a doctor's consultation.
- Before: Reel of a doctor holding a branded vial, caption "B0tox day #baby botox". After: The doctor explaining, in 60 seconds, how muscle-relaxing injections work in general, who shouldn't have them and what recovery looks like. No product in shot.
The pattern is the same each time: name the concern, the clinic and the doctor, and invite a consultation. Let the product choice happen in the consulting room, which is exactly what HSA intends. For paid campaigns, Google and Meta add their own medicine policies on top; see our guide to Google and Meta ads for clinics.
A checklist for aesthetic clinic content
Run every ad, page, post and video through this before it goes live:
- Product names: no brand names, nicknames, misspellings or brand hashtags for any POM or PUO device. Check classifications on HSA Infosearch if unsure.
- Visuals: no identifiable vials, syringes, boxes or pens.
- Generic terms only: "botulinum toxin", "dermal fillers", and only inside balanced, educational content.
- Calls to action: invite a consultation about a concern. No "book your [product]", product quizzes or eligibility checks.
- Comparisons: none between brands, and none between your clinic and others.
- Authority claims: no "HSA approved".
- Pricing: no product-linked prices or bundles unless you have checked with HSA or a lawyer.
- HCSA basics: no before/after or after-only images, testimonials, endorsements, superlatives, promotions or outcome promises.
- Doctor listings: every doctor shown offering injectables is permitted to perform them under the SMC guidelines.
- Creators: written brief, pre-approval and records for every paid or gifted post.
If you'd like a second pair of eyes on your aesthetic marketing, this is a large part of what we do for aesthetic clinics and dermatology practices, from compliant copywriting to paid campaigns.
Frequently asked questions
Can a Singapore clinic say 'Botox' in its ads or social posts?
No. HSA's FAQs for HCSA licensees name Botox as an example of a brand name that must not be referenced when giving the public information on treatments. Botulinum toxin is a prescription-only medicine, and the Health Products (Advertisement of Specified Health Products) Regulations 2016 prohibit advertisements by private persons that relate to prescription-only medicines. Use generic terms such as 'botulinum toxin injections' in balanced, educational content instead.
Are dermal fillers medicines or medical devices in Singapore?
HSA gives hyaluronic acid dermal fillers as an example of a professional-use-only medical device, meaning a device that should only be used by, or under the supervision of, a registered doctor or dentist. HSA does not allow professional-use-only medical devices to be advertised to the public.
Can I spell Botox differently, like 'B*tox' or 'Btx', to get around the rules?
No. HSA's FAQs state that acronyms, deliberate misspellings, creative names and images with masked identifiers that refer to a prescription-only medicine or professional-use-only device are still treated as advertisements of that product.
Can aesthetic clinics post prices for botulinum toxin or filler treatments?
Be careful. HSA's FAQs say educational information on treatments involving health products should not include pricing, and that a product listing with a price and a call to action counts as an offer of sale. Separately, the HCSA rules restrict promotional pricing. Check with HSA's Medical Advertisements unit or a lawyer before publishing any price tied to an injectable.
Does HSA approve aesthetic clinic ads before they run?
No. HSA states that it does not vet or review specific advertising materials. Clinics are expected to read the guidance and legislation themselves and seek legal advice where needed. Writing 'HSA approved' in an ad is also not allowed.
How The Marketing Clinic can help
We're a Singapore healthcare and wellness marketing agency, AI-enabled and part of the Claude Partner Network. We run SEO, AI search, ads and social for clinics, within HCSA advertising rules.